FIELD: medicine.
SUBSTANCE: said container comprises the first end and the second end and at least one inner wall forming a reservoir portion for blood reception, wherein the reservoir contains a mixture comprising thrombin and a polycarboxylic acid compound with molecular weight less than approx. 500 g/mol, and a cover. A method for blood collection is presented as well.
EFFECT: stabilization of thrombin and acceleration of its actions in a blood sample.
15 cl, 7 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
THROMBOSIS MONITOR AND METHOD OF THROMBOSIS MONITORING | 2006 |
|
RU2432577C2 |
METHOD, TEST TUBE AND DEVICE FOR MAKING OF COMPOSITIONS FOR WOUND HEALING | 2011 |
|
RU2667964C1 |
METHOD, TEST TUBE AND DEVICE FOR MAKING OF COMPOSITIONS FOR WOUND HEALING | 2011 |
|
RU2614722C2 |
STABILISED PROTEASE COMPOSITION | 2005 |
|
RU2388486C2 |
METHOD OF CONTROLLING ANTICOAGULANT THERAPY | 2012 |
|
RU2607658C2 |
FACTOR II AND FIBRINOGEN FOR TREATMENT OF HAEMOSTATIC DISORDERS | 2011 |
|
RU2606155C2 |
WHOLE BLOOD THROMBINE ACTIVITY TEST | 2006 |
|
RU2422835C2 |
HIGHLY-SELECTIVE INFESTIN 4-BASED INHIBITOR OF CONTACT ACTIVATION | 2013 |
|
RU2556116C2 |
LIQUID WATER PHARMACEUTICAL COMPOSITION CONTAINING FACTOR VII POLYPEPTIDE | 2004 |
|
RU2388460C2 |
SERUM FRACTION OF THROMBOCYTE-ENRICHED FIBRIN | 2014 |
|
RU2711330C2 |
Authors
Dates
2017-06-19—Published
2012-07-02—Filed